L’Oréal Issues Voluntary Recall of Benzoyl Peroxide Products Over Benzene Concerns

March 11, 2025

L’Oréal announced it is recalling all lots of its acne treatment Effaclar Duo in the U.S. due to concerns over benzene contamination. The product, sold under the La Roche-Posay brand, contains benzoyl peroxide (BPO).

Valisure, an independent testing laboratory, first reported benzene contamination in several BPO-containing acne products more than a year ago, urging the US Food and Drug Administration (FDA) to take action.

Read further analysis at Dermatology Times >>

Previous coverage of reports studying benzene presence in topical acne products formulated with benzoyl peroxide:

Topics in Article

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Raging Agency Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Medical Marketing Whiz Announces Partnership With Boulevard to Help Med Spas and Wellness Clinics Streamline Operations
    • ByrdAdatto Attorneys Recognized in the 2027 Edition of Best Lawyers
    • RHA Redensity Eye Receives FDA Approval for Undereye Hollowing
    • South Carolina Medical Board Warns Against Use of Research-Grade Peptides